Observations placeholder
Metastatic malignant melanoma and Hallucination - from FDA reports
Identifier
024203
Type of Spiritual Experience
Number of hallucinations: 7
Background
There is the complication of malaria and rametinib (trade name Mekinist) - a cancer drug. It is a MEK inhibitor drug with anti-cancer activity. It inhibits MEK1 and MEK2. Trametinib is used for metastatic melanoma carrying the BRAF V600E mutation.
A description of the experience
Metastatic malignant melanoma and Hallucination - from FDA reports
Summary
Hallucination is found among people with Metastatic malignant melanoma, especially for people who are female, 40-49 old, take medication Mekinist and have Malaria. We study 7 people who have Hallucination and Metastatic malignant melanoma from FDA.